Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surinabant for smoking cessation
NCT00432575Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2007
- Primary completion
- Apr 2008
- Countries
- 8
01
Overview
A Phase 2 trial of surinabant in nicotine dependence, sponsored by Sanofi. Started Jan 2007; status: completed.
02
Drugs
surinabant
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00432575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432575.